Ads
related to: cepi stock
Search results
Emergent (EBS) Initiates Study on Lassa Virus Vaccine Candidate
Zacks via Yahoo Finance· 2 years agoEmergent BioSolutions EBS announced the dosing of the first patient in a phase I study evaluating...
Undervalued Biotech Stocks Shine: Pfizer and BioNTech Show Robust Resilience
GuruFocus.com via Yahoo Finance· 8 months agoIn the ever-evolving world of the stock market, uncovering potential gold mines is paramount for...
Within A Month After Pulling Plug On COVID-19 Booster Study, Inovio Shelves Two More Infectious...
Benzinga via Yahoo Finance· 2 years agoInovio Pharmaceuticals Inc (NASDAQ: INO) has agreed with its collaborator, the Coalition for...
3 Reasons to Buy Novavax and 1 to Sell
Motley Fool· 2 years agoNovavax (NASDAQ: NVAX) is a pandemic stock. Now it's down to $50, and the company's market cap is under $4 billion. Here are three arguments for buying...
2 “Strong Buy” Penny Stocks That Could See Huge Long-Term Gains
TipRanks via Yahoo Finance· 2 years agoThe first half of 2022 was marked by concerns over inflation, rising interest rates and recession,...
The Rise and Fall of Novavax
Motley Fool· 2 years agoNovavax (NASDAQ: NVAX) is one of my favorite stocks. Sometimes you'll hear the advice, "Don't fall in love with your stocks." I used to believe that, but...
Moderna (MRNA) Starts Early-Stage Nipah Virus Vaccine Study
Zacks via Yahoo Finance· 2 years agoModerna (MRNA) doses the first participant in the phase I study of its investigational mRNA vaccine,...
China's Clover says its COVID booster shot candidate lifts antibody against Omicron
Reuters via Yahoo News· 2 years agoChina's Clover Biopharmaceuticals said on Monday a booster shot of its COVID-19 vaccine candidate...
Novavax (NVAX) Cancels COVID Jab Supply Deal With GAVI
Zacks via Yahoo Finance· 2 years agoNovavax (NVAX) claims that GAVI's failure to procure its COVID vaccine doses is a reason to...
IQVIA Holdings Inc. (NYSE:IQV) Q4 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 3 months agoIQVIA Holdings Inc. (NYSE:IQV) Q4 2023 Earnings Call Transcript February 14, 2024 IQVIA Holdings...